Back

Intra-Cellular Therapies Stock Predictions

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Buy

ITCI
Intra-Cellular Therapies

Last Price:

89.41

Seasonality Move:

17.18%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Intra-Cellular Therapies Stock Forecast

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 49.2% based on the past 10 years of stock performance.
Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Is Intra-Cellular Therapies Stock Undervalued?
The current Intra-Cellular Therapies [ITCI] share price is $89.24. The Score for ITCI is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
ITCI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 49.2% based on the past 10 years of stock performance.

Intra-Cellular Therapies Stock Rating

Buy

Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies overpriced?

Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

intracellulartherapies.com

52-Week Data

52-Week High:

89.44

52-Week Low:

52.88

Prediction Charts

Market Cap:

9.46B

Price in USD:

89.24

Volume:

507.24K

Beta:

1.05

Technical Analysis

SMA50:

75.65

SMA100:

75.27

SMA200:

72.06

52-Wk Change:

62.28%

Stock Predictions

Is Intra-Cellular Therapies stock public?
Yes, Intra-Cellular Therapies is a publicly traded company.
What is the Intra-Cellular Therapies stock quote today?
The Intra-Cellular Therapies stock price is 89.24 USD today.
How to buy Intra-Cellular Therapies stock online?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Oct-16	75.10	76.09	76.55	74.59
Oct-18	78.22	78.34	79.46	78.04
Oct-21	77.94	76.91	78.47	76.56
Oct-22	76.52	77.09	78.03	76.17
Oct-23	76.52	75.02	76.98	74.76
Oct-24	75.22	75.64	76.04	74.80
Oct-25	75.60	75.81	76.87	75.25
Oct-28	75.93	76.82	77.05	75.58
Oct-29	77.24	76.75	78.02	75.57
Oct-30	78.89	85.46	88.00	76.76
Oct-31	85.01	84.75	86.88	84.57
Nov-1	84.84	86.54	86.98	84.36
Nov-4	86.41	86.17	87.31	86.02
Nov-5	85.79	89.24	89.44	85.08

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.91 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.